Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank71
3Y CAGR-22.6%
5Y CAGR-5.3%
Year-over-Year Change
Operating cash flow minus capital expenditures
3Y CAGR
-22.6%/yr
Annual compound
5Y CAGR
-5.3%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $127.01M | +22.8% |
| 2024 | $103.41M | -43.5% |
| 2023 | $183.15M | -33.1% |
| 2022 | $273.63M | +4.6% |
| 2021 | $261.63M | +56.7% |
| 2020 | $166.99M | +4622.7% |
| 2019 | $3.54M | +104.4% |
| 2018 | $-79.50M | +23.4% |
| 2017 | $-103.77M | +20.0% |
| 2016 | $-129.64M | - |